You are here

  • Home
  • Archive
  • Volume 55, Issue 1
  • The BRCA1 c. 5096G>A p.Arg1699Gln (R1699Q) intermediate risk variant: breast and ovarian cancer risk estimation and recommendations for clinical management from the ENIGMA consortium

Citation Tools

Article menu
Download PDFPDF
Cancer genetics
Short Report
The BRCA1 c. 5096G>A p.Arg1699Gln (R1699Q) intermediate risk variant: breast and ovarian cancer risk estimation and recommendations for clinical management from the ENIGMA consortium

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Moghadasi S, Meeks HD, Vreeswijk MP, et al
The BRCA1 c. 5096G>A p.Arg1699Gln (R1699Q) intermediate risk variant: breast and ovarian cancer risk estimation and recommendations for clinical management from the ENIGMA consortium
Journal of Medical Genetics 2018;55:15-20.